Core Viewpoint - The announcement details the completion of the transfer of shares held by a major shareholder, Shanghai Yueye, following a court-ordered auction, and outlines the upcoming fifth auction of remaining shares [3][4][10]. Group 1: Share Auction Details - Shanghai Yueye's shares were auctioned based on a liquidation plan confirmed by the Shanghai Third Intermediate People's Court [3]. - The fourth auction resulted in the successful transfer of 65,088,066 shares, which is 3.01% of the company's total share capital, while 323,800,000 shares remain for the fifth auction [4][6]. - The fifth auction is scheduled from May 15, 2025, to May 16, 2025, with a minimum bidding quantity reduced from 1 million shares to 500,000 shares [7][8]. Group 2: Shareholder Information - As of the announcement date, Shanghai Yueye has cumulatively auctioned 90,338,066 shares, representing 4.17% of the company's total share capital [10]. - The shares auctioned are classified as unrestricted tradable shares, although they are subject to certain selling restrictions [6][10]. - Shanghai Yueye is not the controlling shareholder, and the auction of its shares will not affect the company's control or normal operations [13]. Group 3: Compliance and Regulatory Information - The auction process complies with relevant laws and regulations, including the Securities Law and the Shenzhen Stock Exchange's self-regulatory guidelines [12]. - The company will continue to monitor the auction process and fulfill its information disclosure obligations as required [13].
德展大健康股份有限公司关于持股5%以上股东所持公司股份拍卖过户完成及第五次拍卖的提示性公告